MedPath

The Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail Injection

Phase 4
Withdrawn
Conditions
Nail Diseases
Interventions
Device: External thermomechanical device delivering cold and vibration stimuli
Drug: Ethyl chloride skin refrigerant spray
Device: External thermomechanical device without delivering cold and vibration stimuli
Registration Number
NCT04422795
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

The purpose of this study is to assess the efficacy and safety of a thermomechanical device delivering vibration and cold stimuli in lowering pain during intramatricial nail injections

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Men and women aged 18 years or older
  • Must understand and voluntarily sign an informed consent form
  • All patients undergoing intramatricial nail injections at the Weill Cornell Medicine (WCM) Department of Dermatology
  • Willingness to participate in the study
Exclusion Criteria
  • Inability of the patient to provide written informed consent for any reason
  • Failure to have nail injection performed
  • Likely inability to comply with the study protocol or cooperate fully with the research team

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
External thermomechanical device delivering stimuliExternal thermomechanical device delivering cold and vibration stimuliThe thermomechanical device is placed on the digit proximally to the injection site with the ice wings frozen and the vibration mechanism switched on.
Nail injection with ethyl chloride skin refrigerant sprayEthyl chloride skin refrigerant sprayEthyl chloride skin refrigerant spray is applied to the area of injection immediately before needle insertion
External thermomechanical device without delivering stimuliExternal thermomechanical device without delivering cold and vibration stimuliThe thermomechanical device is placed on the digit proximally to the injection site with the ice wings at room temperature (unfrozen) and the vibration mechanism switched off.
Primary Outcome Measures
NameTimeMethod
The level of pain and change in pain between each time point will be assessed using the Wong-Baker FACES scale with use of thermomechanical device delivering stimuli, without delivering stimuli, and with use of ethyl chloride skin refrigerant spray.prior to treatment, immediately after the needle insertion, during infiltration and 5 seconds after needle extraction

Pain will be self-reported, using the Wong-Baker FACES (0-10, with 0 representing absence of pain and 10 unbearable pain). Participants will be questioned about their level of pain in their nail prior to treatment, immediately after the needle insertion, during infiltration, and 5 seconds after needle extraction

Secondary Outcome Measures
NameTimeMethod
Number of participants with at least one adverse eventPatients will be followed for 3 days following their nail injection

Adverse events will only include those that are determined to be related to the study device

Trial Locations

Locations (1)

Weill Cornell Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath